CLINICAL FLOW CYTOMETRY INTELLIGENCE
Independent analysis for the future of clinical flow cytometry.
Clinical practice · Validation · Technology · AI & Data · Industry
LATEST INTELLIGENCE
View archive →ANALYSIS · TECHNOLOGY
The 40-Colour Race May Be Ending
Read article →Very high-parameter panels are technically impressive. Clinical value increasingly depends on standardisation, reproducibility and interpretable workflow design.
PAPER INTO PRACTICE
The Best CD38 Antibody Depends on the Therapy
Read article →Clone choice must be validated against treatment context.
VALIDATION & QC
Can Spectral AML MRD Be Standardised Across Multiple Centres?
Read article →The unit of validation is the full network, not the cytometer alone.
EXPLORE CFCM
Clinical Flow
MRD, haematological malignancies, panels and clinical interpretation.
02Validation & QC
CLSI H62, LoB/LoD/LoQ, precision, carryover and reference intervals.
03Technology
Spectral cytometry, analysers, reagents and workflow innovation.
04AI & Data
Clinical AI, foundation models, governance and high-dimensional analysis.
05Industry
Companies, products, European market entry and competitive intelligence.
THE CFCM STANDARD
Not more cytometry news. More signal.
CFCM connects scientific evidence, clinical practice and market intelligence. Every topic is judged by the same question: what changes in practice?
CFCM BRIEF
Read the evidence. Understand the limits. Apply the insight.
Read evidence-based articles, practical Clinical Notes and the Resources library. Historical dates identify original reports; expanded web articles include current editorial review.